New Standard in Pathology

Hong Kong, Hong Kong

Short Summary

Currently there is a gap in pathology laboratory quality and process control for stained microscope slides. Process Record Slide (PRS) was specifically created to fill that gap. PRS has been FDA and CFDA cleared as calibrating consumable device.

Highlights

  • Control Targets Co-reside with Patients Samples
  • 100% QC is now Economically Viable
  • Calibrated Target Baseline enables True Quantifiable Diagnosis
  • The missing link to fulfill ISO 15189
  • The Only Solution to Digital Solution and Objective Diagnosis
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Overview

Target
HK$50,000,000
Minimum
HK$500,000
Investment Raised
N/A
Previous Rounds HK$3,000,000
Stage MVP/Finished Product
Investor Role Any

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 169,894 investors before you know it.

Create New Account
Already have an account?


By clicking "Create New Account" I certify that I agree to the website's Hong Kong - Terms and Conditions and that I understand it is my responsibility to do due diligence on any investor I meet via this platform.

Similar Projects

Global Pro
0% raised

Toilet Hygiene Revolution

Hong Kong

Freshlee Systems will provide a solution to the bathroom environment that is so simple and effective that it will blow people away. Our product not only helps remove odours and airborne viruses from the atmosphere it also reduces energy consumption.

HK$ 1,500,000

Target

HK$ 500,000

Min per Investor

Pro
40% raised

Ai In Healthcare

Outside Hong Kong, Singapore

We are a Singapore AI health-tech startup that monitor patients and elderly people in ward with cameras, enabling nurses to get notified for emergent situations and provide proactive care at all times.

HK$ 1,500,000

Target

HK$ 200,000

Min per Investor

0% raised

StarPlus of Switzerland

Hong Kong

The ultimate baby nappy disposal solution.

HK$ 1,500,000

Target

HK$ 250,000

Min per Investor

load one similar proposal
arrow_upward